Differential DNA methylation profiles in gynecological cancers and correlation with clinico-pathological data

by Tsang Percy CK, Wang Yue, Liu Vincent WS, Yang Hui-Juan, Ngan Hextan YS
Published 2006-08-01

Over-expressions of <it>AMPK</it> subunits in ovarian carcinomas with significant clinical implications

by Li Cuilan, Liu Vincent WS, Chiu Pui M, Chan David W, Ngan Hextan YS
Published 2012-08-01

Loss of Programmed cell death 4 (Pdcd4) associates with the progression of ovarian cancer

by Cheung Annie NY, Liao Xiao Y, Tam Kar F, Leung Thomas HY, Liu Stephanie S, Wei Na, Chan Karen KL, Ngan Hextan YS
Published 2009-09-01

Overexpression of proto-oncogene FBI-1 activates membrane type 1-matrix metalloproteinase in association with adverse outcome in ovarian cancers

by Le Xiao-Feng, Ngan Hextan YS, Lam Eric W-F, Tam Kar, Wong Oscar GW, Siu Michelle KY, Jiang LiLi, Wong Esther SY, Chan Hoi, Cheung Annie NY
Published 2010-12-01